Cargando…
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
Autores principales: | Zhang, Xiaoyu, He, Xiaoqin, Li, Yue, Xu, Yangtao, Chen, Wenliang, Liu, Xin, Hu, Xinyao, Xiong, Lin, Xu, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727543/ https://www.ncbi.nlm.nih.gov/pubmed/35004862 http://dx.doi.org/10.3389/fmolb.2021.826905 |
Ejemplares similares
-
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021) -
Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma
por: Ngo, Tin, et al.
Publicado: (2019) -
Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021) -
Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022) -
Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
por: Feng, Huan, et al.
Publicado: (2020)